Exscientia | Results Presentation Deck | 19 slides · page 12 of 19
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a transition point at RP2D (Recommended Phase 2 Dose).
Conference presentation · roadmap · plan_implementation · dense density
Slide locked Sign in to view
Slide schematic 5/5
diagram 1/1 disclaimer 1/1 paragraph 1/1 title 2/2
Components 5
process disclaimer paragraph action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1